Daily equity-report by epic research 9 jan 2013

325 views

Published on

Epic Research is a leading financial services provider with presence in Indian and other global capital markets. Provides Stock Tips, Forex Tips, Commodity Tips, MCX Tips, Equity Tips, Tips, Intraday Tips, NSE Tips, BSE Tips, COMEX Tips, PCG Pack and NCDEX Tips. We provide services in equity, commodity and Forex market.

  • Be the first to comment

  • Be the first to like this

Daily equity-report by epic research 9 jan 2013

  1. 1. HEADLINES -=6  Indian Market Indian equity markets up by 0.22% Nifty up by 13.30 pts and settle at 6001.70 Sensex up by 51.10 pts at 19742.52 Bank Nifty up by 16.80 pts at 12725.50  Global Market DAILY EQUITY European markets were up with FTSE NEWSLETTER up by 6.93 closed at 6071,CAC up by 14.52 closed at 3719 and DAX down by 9TH JANUARY 2013 5.16 closed at 7727. Dow future was down 10.00 closed at 13297.00  HEADLINES• Fitch renews warning on Indias outlook; rupee falls• MOIL plans to up production, invest Rs 1,200 cr in phases• Biocon gets DCGI approval to market anti-psoriasis drug• 25 bps rate cut wont push bonds further: HDFC Bank WWW.EPICRESEARCH.CO 09752199966
  2. 2.  MARKET ANALYSIS:  Key benchmark indices edged higher after Prime Minister Dr. Manmohan Singh said that despite domestic constraints and challenges, India is confident that the strong economic fundamentals, backed by sound policies, will enable the country to return to a higher growth path. Gains in European stocks also supported domestic bourses.  The BSE Sensex was up 55.06 points or 0.28% to 19,746.48.  S&P CNX Nifty was up 14.45 points or 0.24% to 6,002.85.  Among the 30-share Sensex pack, 16 rose while the rest of them fell.  FMCG stocks gained on renewed buying. Godrej Consumer Products, Tata Global Beverages, Hindustan Unilever, Dabur India and Nestle India gained by 0.04% to 1.02%. Pharma stocks edged higher on renewed buying. Sun Pharmaceutical Industries rose 1.28%.Cipla gained 1.58% to Rs 430. The stock hit record high of Rs 431.70 in intraday trade today, 8 January 2013.Dr Reddys Laboratories rose 1.05% to Rs 1,906.50. The stock hit record high of Rs 1,919.25 in intraday trade today, 8 January 2013. racle Financial Services Software jumped 3.18% to Rs 3376.65. The stock hit record high of Rs 3395 in intraday trade today, 8 January 2013. STOCKS TO WATCH  FII’s and DII’s  TATA STEELCATEGORY DATE BUY SELL NET  LT FII 8-Jan-13 3177.07 2289.69 887.38  PETRONET  ONGC DII 8-Jan-13 735.4 1763.52 -1028.12 SCRIPS IN BAN PERIOD  NIFTY DAILY PIVOTS  SUZLONPIVOT R4 R3 R2 R1 PP S1 S2 S3 S4  KTKBANKNIFTY 6119 6076 6033 6017 5990 5974 5947 5904 5861  RENUKA  IFCI WWW.EPICRESEARCH.CO 09752199966
  3. 3. .  GAINERS AND LOOSERS EXPERT OPINION NIFTY DAILY NIFTY GAINERS  Nifty looks ConsolidateSCRIPS RATE VOL. PR. NET %  Strategy: Sell on rise (000) CLOSE CHAN CHANG GE E  Support: 5960  Resistance: 6050Reliance 567.10 2738.98 550.95 16.15 2.93 Infra BANK NIFTY ITC 285.70 8956.38 279.05 6.65 2.38  Bank Nifty looks Consolidate  Strategy: Sell on rise HDFC 840.30 1812.48 822.95 17.35 2.11  Support: 12650 Power 116.45 4020.41 114.40 2.05 1.79  Resistance: 12800 Grid  .0 BHEL 243.90 2987.66 239.80 4.10 1.71 PREVIOUS PERFORMANCE TYPE SCRIP B/S RESULT DAILY NIFTY LOOSERS HINDUSTAN CASH B SL TRIGERRED PETROLEUMSCRIPS RATE VOL. PR. NET % NOT (000) CLOSE CHAN CHAN CASH ITC S EXECUTED GE GE FUTURE HCL S SL TRIGERRED IDFC 180.40 4857.41 183.90 -3.50 -1.90 ADANI NOT FUTURE B Tata POWER EXECUTED 433.35 3776.39 440.90 -7.55 -1.71 Steel Wipro 398.15 1094.73 404.95 -6.80 -1.68 Sesa Goa 199.70 1443.32 202.65 -2.95 -1.46 UPCOMING RESULTS Larsen & GUJ NRE COKE 1566.90 2653.80 1588.15 -21.25 -1.34 Toubro INDUSIND BANK KITEX GARMENTS YASH MANAGE 09752199966
  4. 4. MARKET CALLS CASH SCRIPS ACTION LEVEL 1ST TARGET 2ND TARGET STOP LOSS PETRONET BUY 167.20 168.20 169.70 166.20 LARSEN TOURBO SELL 1565.00 1561.00 1555.00 1569.00 FUTURE ST ND SCRIPS ACTION LEVEL 1 TARGET 2 TARGET STOP LOSS. TATA STEEL SELL 436.00 432.00 426.00 440.00 ONGC BUY 293.00 295.00 298.00 291.00 Disclaimer The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.

×